vimarsana.com

Page 8 - சீரம் நிறுவனம் ஆஃப் இந்தியா பிரைவேட் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet

Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet

Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Serum s Covishield Vaccine Priced at Rs400 for State Govts, Rs600 for Private Hospitals

Serum’s Covishield Vaccine Priced at Rs400 for State Govts, Rs600 for Private Hospitals Moneylife Digital Team  0 Serum Institute of India Pvt Ltd (SII), the Covishield vaccine maker, says as per the union government directives it has decided to sell its vaccine at Rs400 per dose to state governments and at Rs600 per dose to private hospitals. The central government would receive the Oxford-AstraZeneca COVID-19 vaccine, Covishield at Rs150 per dose for its order of 100 million doses.   In a statement, Adar C Poonawala, chief executive of Serum Institute says, Considering the global vaccine prices, we are ensuring that our vaccines are affordable in comparison with any other vaccines in the world.

El Gobierno busca destrabar la llegada de dos millones de vacunas de Sinopharm y nuevos lotes de la Sputnik V

El Gobierno busca destrabar la llegada de dos millones de vacunas de Sinopharm y nuevos lotes de la Sputnik V
tn.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tn.com.ar Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.